Objective: To define and investigate key issues in the management of dementia and to make
literature-based treatment recommendations. Methods: The authors searched the literature …

Pentoxifylline (oxpentifylline) is a methylxanthine derivative with potent hemorrheologic
properties. In the United States it is marketed for the treatment of intermittent claudication …

The aim of the reported trial was to investigate the safety and efficacy of memantine in mild
to moderate vascular dementia (VaD). This was a 28-week, double-blind, parallel …

Abstract The US elderly (65+) and oldest-old (85+) populations are growing rapidly which,
combined with their high per capita acute and long-term care needs, will increase total US …

Pentoxifylline is a methylxanthine derivative that has been used for several decades in the
symptomatic management of intermittent claudication. For reasons that remain fairly …

Background Vascular dementia (VAD) is the second most common type of dementia lacking
effective treatments. Pentoxifylline (PTX), a nonselective phosphodiesterase inhibitor …

Vascular dementia (VaD) is an etiologic category that includes clinical forms of dementia
caused by ischemic or hemorrhagic cerebrovascular disease (CVD) or by ischemic-hypoxic …

Vascular dementia (VaD) is a major contributor to the dementia syndrome and is described
as having problems with reasoning, planning, judgment, and memory caused by impaired …

We evaluated the efficacy and safety of the centrally acting cholinesterase inhibitor,
rivastigmine tartrate, for patients with mild to moderately severe Alzheimer's disease (AD) …

Synopsis Pentoxifylline (oxpentifylline) has been used widely in the treatment of intermittent
claudication, a prevalent condition in the elderly population. The exact mechanism (s) of …